194 related articles for article (PubMed ID: 36373563)
1. Pharmaceutical liposomal delivery-specific considerations of innovation and challenges.
Peng T; Xu W; Li Q; Ding Y; Huang Y
Biomater Sci; 2022 Dec; 11(1):62-75. PubMed ID: 36373563
[TBL] [Abstract][Full Text] [Related]
2. Challenges in development of targeted liposomal therapeutics.
Sawant RR; Torchilin VP
AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
[TBL] [Abstract][Full Text] [Related]
3. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
Andresen TL; Jensen SS; Jørgensen K
Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
[TBL] [Abstract][Full Text] [Related]
4. New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage.
Cern A; Marcus D; Tropsha A; Barenholz Y; Goldblum A
J Control Release; 2017 Apr; 252():18-27. PubMed ID: 28215669
[TBL] [Abstract][Full Text] [Related]
5. Liposomal Delivery Systems: Design Optimization and Current Applications.
Abu Lila AS; Ishida T
Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
[TBL] [Abstract][Full Text] [Related]
6. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.
Liu P; Chen G; Zhang J
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209162
[TBL] [Abstract][Full Text] [Related]
7. Recent advancements in liposome technology.
Filipczak N; Pan J; Yalamarty SSK; Torchilin VP
Adv Drug Deliv Rev; 2020; 156():4-22. PubMed ID: 32593642
[TBL] [Abstract][Full Text] [Related]
8. Liposomal delivery of vascular endothelial growth factor/receptors and their inhibitors.
Khodabakhsh F; Muyldermans S; Behdani M; Kazemi-Lomedasht F
J Drug Target; 2020 Apr; 28(4):379-385. PubMed ID: 31822133
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in liposomal dry powder formulations: preparation and evaluation.
Misra A; Jinturkar K; Patel D; Lalani J; Chougule M
Expert Opin Drug Deliv; 2009 Jan; 6(1):71-89. PubMed ID: 19236209
[TBL] [Abstract][Full Text] [Related]
10. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
11. Nanobowl-Supported Liposomes Improve Drug Loading and Delivery.
Chen ZJ; Yang SC; Liu XL; Gao Y; Dong X; Lai X; Zhu MH; Feng HY; Zhu XD; Lu Q; Zhao M; Chen HZ; Lovell JF; Fang C
Nano Lett; 2020 Jun; 20(6):4177-4187. PubMed ID: 32431154
[TBL] [Abstract][Full Text] [Related]
12. Liposomal antibiotics for the treatment of infectious diseases.
Alhariri M; Azghani A; Omri A
Expert Opin Drug Deliv; 2013 Nov; 10(11):1515-32. PubMed ID: 23886421
[TBL] [Abstract][Full Text] [Related]
13. [Methods to increase the encapsulation efficiency for liposomal drugs].
Kaszás N; Budai M; Budai L; Gróf P; Zimmer A; Klebovich I
Acta Pharm Hung; 2008; 78(2):69-74. PubMed ID: 18807386
[TBL] [Abstract][Full Text] [Related]
14. Liposomal drug formulations in the treatment of rheumatoid arthritis.
van den Hoven JM; Van Tomme SR; Metselaar JM; Nuijen B; Beijnen JH; Storm G
Mol Pharm; 2011 Aug; 8(4):1002-15. PubMed ID: 21634436
[TBL] [Abstract][Full Text] [Related]
15. Safety of novel liposomal drugs for cancer treatment: Advances and prospects.
He K; Tang M
Chem Biol Interact; 2018 Nov; 295():13-19. PubMed ID: 28919304
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
17. The application strategy of liposomes in organ targeting therapy.
Xun Z; Li T; Xue X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1955. PubMed ID: 38613219
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.
Bitounis D; Fanciullino R; Iliadis A; Ciccolini J
ISRN Pharm; 2012; 2012():738432. PubMed ID: 22474607
[TBL] [Abstract][Full Text] [Related]
19. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
[TBL] [Abstract][Full Text] [Related]
20. Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors.
Dicheva BM; Koning GA
Expert Opin Drug Deliv; 2014 Jan; 11(1):83-100. PubMed ID: 24320104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
